| Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade M Schmittnaegel, N Rigamonti, E Kadioglu, A Cassará, C Wyser Rmili, ... Science translational medicine 9 (385), eaak9670, 2017 | 537 | 2017 |
| Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil Z Lei, IB Tan, K Das, N Deng, H Zouridis, S Pattison, C Chua, Z Feng, ... Gastroenterology 145 (3), 554-565, 2013 | 499 | 2013 |
| Oncogenic pathway combinations predict clinical prognosis in gastric cancer CH Ooi, T Ivanova, J Wu, M Lee, IB Tan, J Tao, L Ward, JH Koo, ... PLoS genetics 5 (10), e1000676, 2009 | 446 | 2009 |
| Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy IB Tan, T Ivanova, KH Lim, CW Ong, N Deng, J Lee, SH Tan, J Wu, ... Gastroenterology 141 (2), 476-485. e11, 2011 | 431 | 2011 |
| Genetic algorithms applied to multi-class prediction for the analysis of gene expression data CH Ooi, P Tan Bioinformatics 19 (1), 37-44, 2003 | 355 | 2003 |
| STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation H Tye, CL Kennedy, M Najdovska, L McLeod, W McCormack, N Hughes, ... Cancer cell 22 (4), 466-478, 2012 | 322 | 2012 |
| Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity C Baer, ML Squadrito, D Laoui, D Thompson, SK Hansen, A Kiialainen, ... Nature cell biology 18 (7), 790-802, 2016 | 272 | 2016 |
| Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer HK Oh, ALK Tan, K Das, CH Ooi, NT Deng, IBH Tan, E Beillard, J Lee, ... Clinical cancer research 17 (9), 2657-2667, 2011 | 223 | 2011 |
| Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity S Hoves, CH Ooi, C Wolter, H Sade, S Bissinger, M Schmittnaegel, O Ast, ... Journal of Experimental Medicine 215 (3), 859-876, 2018 | 219 | 2018 |
| Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like … CA Gomez-Roca, A Italiano, C Le Tourneau, PA Cassier, M Toulmonde, ... Annals of Oncology 30 (8), 1381-1392, 2019 | 172 | 2019 |
| Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer Y Wu, H Grabsch, T Ivanova, IB Tan, J Murray, CH Ooi, AI Wright, NP West, ... Gut 62 (8), 1100-1111, 2013 | 170 | 2013 |
| Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response C Salvagno, M Ciampricotti, S Tuit, CS Hau, A van Weverwijk, SB Coffelt, ... Nature cell biology 21 (4), 511-521, 2019 | 167 | 2019 |
| Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer T Ivanova, H Zouridis, Y Wu, LL Cheng, IB Tan, V Gopalakrishnan, ... Gut 62 (1), 22-33, 2013 | 113 | 2013 |
| Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy AS Kashyap, M Schmittnaegel, N Rigamonti, D Pais-Ferreira, P Mueller, ... Proceedings of the National Academy of Sciences 117 (1), 541-551, 2020 | 88 | 2020 |
| CD44-SLC1A2 gene fusions in gastric cancer J Tao, NT Deng, K Ramnarayanan, B Huang, HK Oh, SH Leong, SS Lim, ... Science translational medicine 3 (77), 77ra30-77ra30, 2011 | 88 | 2011 |
| Patterns of large-scale genomic variation in virulent and avirulent Burkholderia species C Ong, CH Ooi, D Wang, H Chong, KC Ng, F Rodrigues, MA Lee, P Tan Genome research 14 (11), 2295-2307, 2004 | 82 | 2004 |
| Macrophage susceptibility to emactuzumab (RG7155) treatment LP Pradel, CH Ooi, S Romagnoli, MA Cannarile, H Sade, D Rüttinger, ... Molecular cancer therapeutics 15 (12), 3077-3086, 2016 | 81 | 2016 |
| Tissue-specific immunoregulation: a call for better understanding of the “immunostat” in the context of cancer W Pao, CH Ooi, F Birzele, A Ruefli-Brasse, MA Cannarile, B Reis, ... Cancer discovery 8 (4), 395-402, 2018 | 80 | 2018 |
| Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma AME Bröske, K Korfi, A Belousov, S Wilson, CH Ooi, CR Bolen, ... Blood advances 6 (3), 1025-1037, 2022 | 54 | 2022 |
| Integrative Genomic, Transcriptional, and Proteomic Diversity in Natural Isolates of the Human Pathogen Burkholderia pseudomallei K Ou, C Ong, SY Koh, F Rodrigues, SH Sim, D Wong, CH Ooi, KC Ng, ... Journal of bacteriology 187 (12), 4276-4285, 2005 | 52 | 2005 |
Patrick TanDuke-NUS Medical SchoolPatvirtintas el. paštas duke-nus.edu.sg
